𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas

✍ Scribed by Angels Sierra; Xavier Castellsagué; Toni Coll; Sandra Mañas; Agustin Escobedo; Abelardo Moreno; Angels Fabra


Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
165 KB
Volume
79
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Expression of the death-related proteins (DRPs) Bcl-2, Bax, Bcl-x and Bak that regulate cell survival and death was examined using immuno-histochemical methods in a group of 142 T 1 (F2 cm) ductal breast carcinomas. Immunostaining results were correlated with loss of apoptosis and clinicopathological parameters such as histological grade (HG) and lymph node involvement. Expression of anti-apoptotic proteins Bcl-2 and Bcl-x was found in 57.0% and 62.75% of tumors, respectively. Bcl-2 expression, but not Bcl-x expression, was related to loss of apoptosis. Expression of the apoptotic proteins Bax and Bak was present in 58% of Bcl-2-negative tumors and associated significantly with an increase in apoptosis. Expression of these DRPs was associated significantly with the HG of the tumors: Bcl-2 and Bak expression was predominant in HG I/II tumors, whereas expression of Bcl-x L and Bax was commonly observed in HG III tumors, as occurs for p53 over-expression. Our results suggest that the loss or gain of apoptosis is regulated tightly in T 1 breast carcinomas through the expression of different effectors along with tumor cell differentiation.


📜 SIMILAR VOLUMES


c-myc, p53 and bcl-2, apoptosis-related
✍ Monique G. Lê; Marie-Christine Mathieu; Setha Douc-Rasy; Marie-Luce Le Bihan; Ho 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB 👁 1 views

Apoptosis is an important physiological process controlled by multiple genes, including c-myc, p53 and bcl-2, and its inhibition may lead to the development of human cancers. In this study, we analyzed expression of the c-myc gene using Northern blot and of the p53 and bcl-2 proteins by immunohistoc

Loss of heterozygosity at 11q23.1 in bre
✍ Kirsten Laake; Åse Ødegård; Tone Ikdahl Andersen; Ida K. Bukholm; Rolf Kåresen; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Previous reports have suggested that heterozygotes for ataxia-telangiectasia (A-T) have an increased risk of cancer, in particular breast cancer. The ATM gene, responsible for A-T, was recently cloned. Loss of heterozygosity (LOH) in the chromosome band 11q23, where the ATM gene is located, has been

Mechanisms of escape from CD8+ T-cell cl
✍ Koji Kono; Eva Halapi; Christina Hising; Max Petersson; Eva Gerdin; Farkas Vanky 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 208 KB 👁 1 views

We have developed an in vitro model to study mechanisms by which ovarian tumor cells that over-express the HER-2/ neu proto-oncogene escape recognition by T CD8 1 . Nine tumorspecific, HLA A2-restricted T CD8 1 clones were isolated from 2 ovarian tumor-specific T CD8 1 lines derived from tumorinfilt